Myriad Genetics | MYGN - Efectivo Y Equivalentes





Efectivo Y Equivalentes Cambio Fecha
Agilent USD 1.76B 31M 2025-12
Becton, Dickinson and Co. USD 813M 73M 2026-03
Bio-Rad Laboratories USD 507.2M 22.6M 2026-03
Bruker USD 133.4M 165.4M 2026-03
Danaher USD 5.7B 1.09B 2026-03
Illumina USD 1.42B 368M 2025-12
J&J USD 21.69B 1.98B 2026-03
Mettler Toledo International USD 66.89M 2.18M 2025-12
Myriad Genetics USD 124.4M 25.2M 2026-03
OraSure Technologies USD 176.96M 22.31M 2026-03
Pacific Biosciences Of California USD 56.27M 223.23M 2026-03
Quest Diagnostics USD 393M 27M 2026-03
Quidel USD 140.4M 29.4M 2026-03
Repligen USD 582.65M 16.63M 2026-03
Revvity USD 860.32M 59.54M 2026-03
Standard Biotools USD 265.77M 147.56M 2026-03
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Veracyte USD 263.14M 99.44M 2026-03
Waters USD 462M 125.83M 2026-03